Description
Preterm Infants diagnosed with pauses in breathing (apnea of prematurity) and treated for intermittent hypoxia using caffeine sought for study of longer-term caffeine treatment
Overview
We are studying whether continuing caffeine treatment for pre-term infants with apnea of prematurity (pauses in breathing) for an additional 7 to 10 weeks after when treatment would usually end helps to prevent drops in oxygen levels in the blood (intermittent hypoxia)
What we're hoping for
We hope to get a better sense of when would be the best time to stop treating pre-term infants with caffeine to prevent pauses in breathing that may result in drops in oxygen levels in their blood
Additional Information
ClinicalTrials.gov Identifier: NCT03321734